Washington, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Advance the availability of safe and effective regenerative cell therapies for patients in need.
1.In support of its goal to advance therapies to support patients in need, the organization convened an advisory group comprised of scientists, researchers, clinical experts, and patients to guide...
1.In support of its goal to advance therapies to support patients in need, the organization convened an advisory group comprised of scientists, researchers, clinical experts, and patients to guide the development of policy actions needed to advance the field. 2.In support of its goal to advance therapies to support patients in need through education and advocacy, the organization developed white papers, briefs, and other communications materials raise aware awareness of the current state of the field, barriers to progress, and policy actions needed. 3. In support of its goal to advance therapies to support patients in need, the organization assessed the federal government's progress
against legislative requirements and other federal policies. 4. In support of its goal to advance therapies to support patients in need, the organization successfully advocated for public policy to...
against legislative requirements and other federal policies. 4. In support of its goal to advance therapies to support patients in need, the organization successfully advocated for public policy to encourage greater investment in clinical trials, the characterization, optimization and scaling of manufacturing, and collaborative evidence development and transparency related to such therapies.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | N/A | $350,000 | -1.0% |
| Expenses | $16,004 | $397,552 | -1.0% |
| Net Income | N/A | $-47,552 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JOANNE KURTZBERG | DIRECTOR | N/A |
Director
|
$0 | $0 | $0 |
| FRED SANFILIPPO | DIRECTORCHAIRMAN | N/A |
Officer
Director
|
$0 | $0 | $0 |
| JANET MARCHIBRODA | PRESIDENTSECRETARY | N/A |
Officer
Director
|
$0 | $0 | $0 |
| MICHELE REISNER | TREASURER | N/A |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2023 | No data | $16,004 | $15,189 | No data |
| 2022 | $350,000 | $397,552 | $69,144 | $-47,552 |
| 2021 | $530,000 | $586,690 | $130,611 | $-56,690 |
Compare Alliance for Cell Therapy Now with other nonprofits in District of Columbia and across the country.